modifies treats in guideline Drug Acute Chest Syndrome Severe Anemia Nephropathy Hereditary Persistence of Fetal Hemoglobin Sickle Cell Disease-SD Sickle Cell Chronic Lung Disease Clinical Phenotype of Beta Thalassemia Hemoglobin C Disease Hemoglobin E Disease Hydroxyurea Hydroxycarbamide An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. SCDO:0000580 Sufficient Hydrea Oncocarbide MESH:D006918 Phenotype of Sickle Cell Disease Preventative Therapeutics Recurrent Wheeze in Sickle Cell Disease Recommendations for the Management of Sickle Cell Disease in South Africa National Guideline for the Control and Management of Sickle Cell Disease Management of Sickle Cell Disease - The United Republic of Tanzania A Parental Guide to Managing Sickle Cell Disease Standards for Clinical Care of Adults with Sickle Cell Disease in the UK Sickle Cell Disease: The Clinical Care Guidelines of the Sickle Cell Unit Consensus Statement on the Care of Patients with Sickle Cell Disease in Canada Sickle Cell Disease in Children, Standards and Guidelines for Clinic Care Evidence-Based Management of Sickle Cell Disease Management of Children with Sickle Cell Disease in Europe: Current Situation and Future Perspectives ENERCA Clinical Recommendations for Disease Management and Prevention of Complications of Sickle Cell Disease in Children Hemoglobin F Level